Kim A Bellows, PA
Physician Assistant · Napa
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
- Since medical school
- 27 years
- Un of California, Irvine, College of Medicine, 1999
Offices
1 location · Napa Valley Orthopaedic Medical Group Inc · 17 clinicians in this group
Looking this up.
Hospitals listed: Adventist Health St Helena · Providence Queen of the Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Kim A Bellows’s office at (707) 254-7117 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health St HelenaSaint Helena, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative respiratory failure rate: 15.08 (9.46 to 20.69) · 531 cases, Jul 2022 – Jun 2024
- Providence Queen of the Valley Medical CenterNapa, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.107, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health St Helena
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 8 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 15.08 (9.46 to 20.69) · 531 cases | Worse | Jul 2022 – Jun 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.91 (0 to 1.92) · 430 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.22 (0.89 to 1.55) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 152.62 (102.81 to 202.43) · 69 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 37 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.5 · 152 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 126 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.5 · 38 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 953 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.06 to 0.48) · 2,438 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,875 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.42 (1.24 to 5.59) · 1,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.59 (1.12 to 4.05) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.66 (1.18 to 4.13) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.91 (3.32 to 10.5) · 529 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 91 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.32) · 2,008 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 56 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.568 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.362 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 194 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 153 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 37.2 · 236 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -41 · 178 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -33.9 · 127 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.5 · 116 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.8 to 7.9) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.2 (8.2 to 14.8) · 150 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 59 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.1 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.5 to 17.4) · 1,276 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 841 cases | No different | Jan 2024 – Dec 2024 |
What patients said (573 patients answered, 28% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Providence Queen of the Valley Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.107 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.92) · 609 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.5 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 191.43 (130.54 to 252.33) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 46 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.1 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 135 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12 · 271 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.7 · 376 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 175 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.41) · 4,152 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 4,188 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (1.63 to 5.99) · 803 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.21) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.62 to 3.77) · 742 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.45 (0.91 to 16) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.58 (1.75 to 9.42) · 250 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 152 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.94) · 2,994 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.684 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.887 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.2 · 133 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 270 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -4.8 · 143 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -22.1 · 316 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -1 · 399 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 20.4 · 337 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.5 to 7.8) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (9.8 to 17.7) · 107 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.4 to 16.2) · 848 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 423 cases | No different | Jan 2024 – Dec 2024 |
What patients said (449 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 40% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$220,897
Medicare paid this office $220,897 for 519 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 434 | $144,220 | $97 |
| Short return visit (20+ min) | 236 | $23,672 | $72 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 21 | $7,333 | $76 |
| Ultrasonic guidance for needle placement | 22 | $4,690 | $49 |
| Injection of trigger points, 1-2 muscles | 56 | $2,957 | $43 |
See all 11 services
| Return visit (30+ min) | 434 | $144,220 | $97 |
| Short return visit (20+ min) | 236 | $23,672 | $72 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 21 | $7,333 | $76 |
| Ultrasonic guidance for needle placement | 22 | $4,690 | $49 |
| Injection of trigger points, 1-2 muscles | 56 | $2,957 | $43 |
| Aspiration and/or injection of fluid from large joint | 17 | $1,060 | $56 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 53 | $691 | $13 |
| Short return visit | 11 | $576 | $48 |
| Injection of drug or substance under skin or into muscle | 13 | $197 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 20 | $75 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 54 | $58 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 151 | 110 | 121 | 117 | 109 | 96 |
| Injection of trigger points, 1-2 muscles | – | – | 29 | 17 | 39 | 68 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 34 | 17 | 33 | 15 | 13 | – |
| Aspiration and/or injection of fluid from large joint | – | – | 21 | – | 13 | 19 |
| Electronic analysis of spinal canal drug infusion pump | 33 | – | – | – | – | – |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 14 | – | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
519 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 15% · Women 62% · Also on Medicaid 19% · Health risk score 1.44. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Depression 32% · Diabetes 31% · Coronary heart disease 27% · Chronic kidney disease 25% · Atrial fibrillation 20% · Cancer 18% · Heart failure 17% · COPD 16% · Stroke 8% · Dementia 6%.
The office billed $575,969, Medicare allowed $291,311 and paid $220,897; for 9,461 services of 35 kinds; $28,988 of it was for drugs given in the office and $191,910 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 519 | 9,461 | 75 | 1.44 | $575,969 | $220,897 |
| 2023 | 438 | 7,366 | 74 | 1.46 | $504,995 | $184,318 |
| 2022 | 447 | 7,249 | 75 | 1.55 | $536,537 | $205,485 |
| 2021 | 396 | 5,546 | 73 | 1.49 | $512,402 | $198,446 |
| 2020 | 510 | 3,310 | 70 | 1.65 | $447,097 | $186,792 |
| 2019 | 392 | 4,397 | 67 | 1.79 | $775,703 | $380,793 |
| 2018 | 368 | 7,170 | 67 | 1.81 | $857,905 | $393,478 |
| 2017 | 315 | 3,114 | 67 | 1.76 | $618,981 | $312,106 |
| 2016 | 196 | 542 | 66 | 1.60 | $105,700 | $36,831 |
| 2013 | 16 | 34 | 65 | 1.29 | $6,930 | $2,558 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 12 services
| Return visit (30+ min) | 372 | $124,923 | $89 |
| Short return visit (20+ min) | 180 | $16,398 | $65 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 24 | $7,821 | $72 |
| Ultrasonic guidance for needle placement | 24 | $4,934 | $45 |
| Injection of trigger points, 1-2 muscles | 29 | $1,508 | $39 |
| X-ray of middle and lower spine, 2 views | 23 | $964 | $28 |
| Short return visit | 15 | $697 | $41 |
| Aspiration and/or injection of fluid from large joint | 13 | $641 | $49 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 11 | $361 | $28 |
| Injection of drug or substance under skin or into muscle | 24 | $319 | $10 |
| Injection, dexamethasone sodium phosphate, 1 mg | 30 | $60 | None |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 15 | $53 | None |
2022: 11 services
| Return visit (30+ min) | 376 | $136,019 | $88 |
| Short return visit (20+ min) | 218 | $21,850 | $64 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 26 | $8,000 | $68 |
| Ultrasonic guidance for needle placement | 26 | $4,945 | $44 |
| Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | 39 | $2,626 | $34 |
| Short return visit | 25 | $1,292 | $40 |
| X-ray of middle and lower spine, 2 views | 20 | $736 | $27 |
| Injection of trigger points, 1-2 muscles | 12 | $655 | $39 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 11 | $493 | $33 |
| Injection of drug or substance under skin or into muscle | 20 | $255 | $11 |
| Injection, dexamethasone sodium phosphate, 1 mg | 21 | $21 | None |
2021: 16 services
| Return visit (30+ min) | 324 | $132,482 | $92 |
| Short return visit (20+ min) | 225 | $25,807 | $64 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 29 | $8,977 | $74 |
| Electronic analysis of implanted neurostimulator generator with simple spinal cord or peripheral nerve stimulator programming | 38 | $3,452 | $37 |
| Ultrasonic guidance for needle placement | 27 | $3,282 | $45 |
| Short return visit | 37 | $2,171 | $43 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 31 | $2,113 | $41 |
| Injection of trigger points, 1-2 muscles | 24 | $1,188 | $41 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 13 | $1,108 | $34 |
| Aspiration and/or injection of fluid from large joint | 16 | $1,052 | $50 |
| X-ray of middle and lower spine, 2 views | 19 | $757 | $28 |
| X-ray of middle spine, 2 views | 14 | $421 | $26 |
| Injection of drug or substance under skin or into muscle | 24 | $389 | $11 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $90 | None |
| Injection, dexamethasone sodium phosphate, 1 mg | 34 | $41 | None |
| Injection, ketorolac tromethamine, per 15 mg | 13 | $20 | None |
2020: 13 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 181 | $75,784 | $241 |
| Short return visit (20+ min) | 260 | $42,077 | $57 |
| Return visit (30+ min) | 243 | $21,730 | $64 |
| Testing for presence of drug, by chemistry analyzers | 181 | $19,081 | $61 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 68 | $7,816 | $71 |
| Unclassified drugs | 45 | $5,762 | None |
| Ultrasonic guidance for needle placement | 54 | $2,829 | $43 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 15 | $921 | $44 |
| Short return visit | 15 | $570 | $36 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 14 | $429 | $25 |
| Injection of drug or substance under skin or into muscle | 19 | $188 | $10 |
| Injection, ketorolac tromethamine, per 15 mg | 19 | $29 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 44 | $1 | None |
2019: 13 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 301 | $202,053 | $242 |
| Return visit (30+ min) | 326 | $61,165 | $75 |
| Testing for presence of drug, by chemistry analyzers | 301 | $52,906 | $63 |
| Unclassified drugs | 90 | $33,217 | None |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 87 | $14,230 | $94 |
| Ultrasonic guidance for needle placement | 83 | $6,332 | $44 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 22 | $1,369 | $40 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 11 | $1,023 | $73 |
| Electronic analysis of spinal canal drug infusion pump | 23 | $902 | $27 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 23 | $573 | $13 |
| Injection of drug or substance under skin or into muscle | 26 | $361 | $11 |
| Injection, ketorolac tromethamine, per 15 mg | 26 | $11 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 82 | $4 | None |
2018: 18 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 239 | $131,655 | $242 |
| Return visit (30+ min) | 336 | $89,408 | $74 |
| Unclassified drugs | 94 | $58,125 | None |
| Testing for presence of drug, by chemistry analyzers | 239 | $38,299 | $70 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | 87 | $17,536 | $97 |
| Complete ultrasound scan of joint | 70 | $10,549 | $77 |
| Ultrasonic guidance for needle placement | 90 | $10,072 | $45 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 57 | $7,151 | $86 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 23 | $2,546 | $54 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 44 | $2,267 | $40 |
| Electronic analysis of spinal canal drug infusion pump | 36 | $1,721 | $30 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 17 | $1,604 | $70 |
| Injection of drug or substance under skin or into muscle | 44 | $890 | $15 |
| Annual alcohol misuse screening, 5 to 15 minutes | 38 | $666 | $18 |
| Annual depression screening, 5 to 15 minutes | 32 | $549 | $17 |
| Psychological testing with interpretation and report by computer | 18 | $350 | $19 |
| Injection, ketorolac tromethamine, per 15 mg | 48 | $56 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 92 | $5 | None |
2017: 14 services
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 216 | $134,125 | $248 |
| Return visit (30+ min) | 269 | $54,208 | $76 |
| Testing for presence of drug, by chemistry analyzers | 216 | $42,277 | $78 |
| Unclassified drugs | 63 | $38,953 | None |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 70 | $14,914 | $91 |
| Complete ultrasound scan of joint | 63 | $11,833 | $96 |
| Ultrasonic guidance for needle placement | 63 | $5,807 | $47 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 17 | $1,689 | $53 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 22 | $1,204 | $42 |
| Electronic analysis of spinal canal drug infusion pump | 29 | $977 | $30 |
| Short return visit (20+ min) | 12 | $662 | $47 |
| Injection of drug or substance under skin or into muscle | 26 | $612 | $20 |
| Injection, ketorolac tromethamine, per 15 mg | 24 | $25 | None |
| Injection, lidocaine hcl for intravenous infusion, 10 mg | 64 | $3 | None |
2016: 9 services
| Return visit (30+ min) | 173 | $21,854 | $78 |
| Electronic analysis reprogramming and refill of spinal canal drug infusion pump | 47 | $6,450 | $93 |
| Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when | 35 | $3,223 | $77 |
| Electronic analysis of implanted brain, spinal cord, or peripheral neurostimulator generator | 14 | $1,457 | $52 |
| Electronic analysis and reprogramming of spinal canal drug infusion pump | 14 | $877 | $44 |
| Electronic analysis of spinal canal drug infusion pump | 14 | $544 | $32 |
| Annual alcohol misuse screening, 5 to 15 minutes | 23 | $408 | $18 |
| Annual depression screening, 5 to 15 minutes | 23 | $408 | $18 |
| Injection of drug or substance under skin or into muscle | 16 | $365 | $20 |
2013: 1 service
| Return visit (30+ min) | 16 | $1,297 | $81 |
Medicaid work
$7,102 in 2024
Medicaid paid $7,102 for 371 billed services this clinician did in 2024, up to 44 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 371 | $7,102 |
| 2024 | 371 | 1 | 44 | $7,102 |
| 2023 | 521 | 2 | 48 | $9,964 |
| 2022 | 526 | 2 | 47 | $9,938 |
| 2021 | 455 | 2 | 48 | $7,792 |
| 2020 | 332 | 4 | 46 | $15,435 |
| 2019 | 86 | 2 | 46 | $1,764 |
| 2018 | 13 | 1 | 12 | $660 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 507 | $9,678 |
| Short return visit (20+ min) | 14 | $286 |
2022
| Return visit (30+ min) | 509 | $9,693 |
| Short return visit (20+ min) | 17 | $245 |
2021
| Return visit (30+ min) | 434 | $7,384 |
| Short return visit (20+ min) | 21 | $408 |
2020
| Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | 31 | $8,314 |
| Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service | 31 | $3,077 |
| Return visit (30+ min) | 133 | $2,916 |
| Short return visit (20+ min) | 137 | $1,128 |
2019
| Return visit (30+ min) | 74 | $1,565 |
| Ultrasonic guidance for needle placement (eg, biopsy, aspiration, injection, localization device), imaging supervision and interpretation | 12 | $199 |
2018
| Return visit (30+ min) | 13 | $660 |
Drugs they prescribed that Part D paid
$135,967
Pharmacies billed $135,967 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 52% of their Part D prescriptions (1,111 of 2,151) in 2024. A higher opioid share than 9 in 10 peers; the typical physician assistant clinician is at 1%. Long-acting opioids: 21% of their opioid prescriptions.
2,036 generic and 115 brand-name prescriptions · $135,967 in drug cost · 19 antibiotic prescriptions to 12 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Buprenorphine | None | 106 | $21,135 | $199 |
| Ubrelvy | None | 14 | $14,494 | $1,035 |
| Emgality | Migraine | 12 | $13,213 | $1,101 |
| Hydrocodone-Acetaminophen | None | 377 | $10,636 | $28 |
| Lidocaine | None | 68 | $9,923 | $146 |
See all 33 drugs
| Buprenorphine | None | 106 | $21,135 | $199 |
| Ubrelvy | None | 14 | $14,494 | $1,035 |
| Emgality | Migraine | 12 | $13,213 | $1,101 |
| Hydrocodone-Acetaminophen | None | 377 | $10,636 | $28 |
| Lidocaine | None | 68 | $9,923 | $146 |
| Ajovy | None | 12 | $8,851 | $738 |
| Oxycodone | None | 194 | $4,956 | $26 |
| Buprenorphine-Naloxone | None | 33 | $3,552 | $108 |
| Oxycodone-Acetaminophen | None | 137 | $3,185 | $23 |
| Tizanidine | None | 210 | $2,575 | $12 |
| Celecoxib | None | 57 | $2,560 | $45 |
| Morphine Sulfate Er | None | 95 | $2,529 | $27 |
| Pregabalin | None | 91 | $2,439 | $27 |
| Gabapentin | None | 97 | $1,629 | $17 |
| Diclofenac | None | 35 | $1,379 | $39 |
| Hydromorphone | None | 47 | $874 | $19 |
| Tramadol | None | 95 | $859 | $9 |
| Duloxetine | None | 18 | $666 | $37 |
| Baclofen | None | 40 | $606 | $15 |
| Cyclobenzaprine | None | 29 | $572 | $20 |
| Methadone | None | 18 | $367 | $20 |
| Amitriptyline | None | 13 | $263 | $20 |
| Buprenorphine | None | 24 | $257 | $11 |
| Methylprednisolone | None | 30 | $233 | $8 |
| Methocarbamol | None | 22 | $164 | $7 |
| Mirtazapine | None | 13 | $163 | $13 |
| Morphine Sulfate | None | 12 | $145 | $12 |
| Zolpidem | None | 12 | $134 | $11 |
| Ibuprofen | None | 15 | $111 | $7 |
| Diazepam | None | 87 | $99 | $1 |
| Sulfamethoxazole-Trimethoprim | None | 11 | $42 | $4 |
| Sertraline | None | 11 | $25 | $2 |
| Sumatriptan | None | 12 | $16 | $1 |
Year by year
| 2024 | 2,151 | 284 | 52% (1,111) | 5% | $135,967 |
| 2023 | 2,119 | 252 | 59% (1,246) | 7% | $127,886 |
| 2022 | 1,922 | 213 | 61% (1,171) | 5% | $112,199 |
| 2021 | 1,861 | 250 | 63% (1,168) | 5% | $108,103 |
| 2020 | 2,261 | 398 | 52% (1,184) | 8% | $129,847 |
| 2019 | 3,714 | 373 | 50% (1,837) | 10% | $221,734 |
| 2018 | 3,807 | 362 | 51% (1,926) | 11% | $227,789 |
| 2017 | 3,753 | 342 | 54% (2,010) | 14% | $264,281 |
| 2016 | 2,615 | 273 | 60% (1,565) | 15% | $226,263 |
| 2015 | 1,935 | 178 | 83% (1,614) | 19% | $202,064 |
| 2014 | 1,628 | 136 | 82% (1,328) | 19% | $143,637 |
| 2013 | 1,297 | 125 | 79% (1,022) | 14% | $79,355 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 35 drugs
| Buprenorphine | None | 61 | $17,485 | $287 |
| Lidocaine | None | 58 | $12,740 | $220 |
| Emgality | Migraine | 14 | $10,357 | $740 |
| Hydrocodone-Acetaminophen | None | 424 | $9,803 | $23 |
| Xtampza Er | None | 11 | $6,703 | $609 |
| Oxycodone | None | 196 | $5,604 | $29 |
| Pregabalin | None | 113 | $5,507 | $49 |
| Morphine Sulfate Er | None | 141 | $5,382 | $38 |
| Oxycodone-Acetaminophen | None | 190 | $4,974 | $26 |
| Tizanidine | None | 168 | $4,314 | $26 |
| Celecoxib | None | 47 | $3,877 | $82 |
| Fentanyl | None | 24 | $1,884 | $79 |
| Codeine Sulfate | None | 13 | $1,493 | $115 |
| Hydromorphone | None | 65 | $1,111 | $17 |
| Buprenorphine-Naloxone | None | 12 | $1,075 | $90 |
| Gabapentin | None | 51 | $781 | $15 |
| Cyclobenzaprine | None | 39 | $658 | $17 |
| Buprenorphine | None | 21 | $617 | $29 |
| Baclofen | None | 31 | $606 | $20 |
| Diclofenac | None | 22 | $587 | $27 |
| Tramadol | None | 60 | $533 | $9 |
| Sumatriptan | None | 14 | $502 | $36 |
| Duloxetine | None | 24 | $477 | $20 |
| Morphine Sulfate | None | 15 | $320 | $21 |
| Meloxicam | None | 15 | $236 | $16 |
| Methadone | None | 20 | $209 | $10 |
| Methylprednisolone | None | 19 | $171 | $9 |
| Zolpidem | None | 12 | $161 | $13 |
| Sertraline | None | 12 | $144 | $12 |
| Mirtazapine | None | 12 | $118 | $10 |
| Methocarbamol | None | 15 | $116 | $8 |
| Amitriptyline | None | 23 | $107 | $5 |
| Buspirone | None | 12 | $102 | $8 |
| Sulfamethoxazole-Trimethoprim | None | 12 | $62 | $5 |
| Diazepam | None | 30 | $22 | $1 |
2022: 33 drugs
| Oxycontin | 24 | $19,962 | $832 |
| Hydrocodone-Acetaminophen | 382 | $11,246 | $29 |
| Oxycodone-Acetaminophen | 219 | $9,273 | $42 |
| Lidocaine | 36 | $8,339 | $232 |
| Oxycodone | 176 | $6,090 | $35 |
| Buprenorphine | 13 | $4,946 | $380 |
| Morphine Sulfate Er | 130 | $4,172 | $32 |
| Pregabalin | 94 | $4,161 | $44 |
| Fentanyl | 38 | $3,704 | $97 |
| Tizanidine | 178 | $3,563 | $20 |
| Hydromorphone | 79 | $1,672 | $21 |
| Gabapentin | 70 | $1,300 | $19 |
| Celecoxib | 22 | $1,064 | $48 |
| Duloxetine | 38 | $1,011 | $27 |
| Amitriptyline | 31 | $932 | $30 |
| Buprenorphine | 21 | $573 | $27 |
| Morphine Sulfate | 21 | $443 | $21 |
| Tramadol | 59 | $434 | $7 |
| Diclofenac | 18 | $402 | $22 |
| Diclofenac Sodium Er | 13 | $351 | $27 |
| Cyclobenzaprine | 27 | $349 | $13 |
| Sertraline | 12 | $252 | $21 |
| Baclofen | 16 | $242 | $15 |
| Buspirone | 12 | $189 | $16 |
| Methocarbamol | 12 | $179 | $15 |
| Ibuprofen | 17 | $150 | $9 |
| Methadone | 12 | $144 | $12 |
| Zolpidem | 16 | $130 | $8 |
| Methylprednisolone | 12 | $103 | $9 |
| Mirtazapine | 13 | $77 | $6 |
| Nortriptyline | 14 | $67 | $5 |
| Meloxicam | 12 | $32 | $3 |
| Diazepam | 18 | $27 | $2 |
2021: 28 drugs
| Oxycontin | 34 | $24,037 | $707 |
| Hydrocodone-Acetaminophen | 327 | $10,840 | $33 |
| Oxycodone-Acetaminophen | 213 | $7,961 | $37 |
| Oxycodone | 192 | $5,664 | $30 |
| Fentanyl | 51 | $4,519 | $89 |
| Lidocaine | 22 | $3,730 | $170 |
| Morphine Sulfate Er | 137 | $3,146 | $23 |
| Buprenorphine | 11 | $2,932 | $267 |
| Tizanidine | 124 | $2,455 | $20 |
| Pregabalin | 62 | $2,145 | $35 |
| Hydromorphone | 77 | $1,957 | $25 |
| Gabapentin | 87 | $1,808 | $21 |
| Celecoxib | 33 | $1,719 | $52 |
| Amitriptyline | 33 | $867 | $26 |
| Diclofenac | 23 | $704 | $31 |
| Tramadol | 59 | $542 | $9 |
| Morphine Sulfate | 21 | $535 | $25 |
| Methocarbamol | 21 | $505 | $24 |
| Baclofen | 19 | $450 | $24 |
| Trazodone | 22 | $441 | $20 |
| Duloxetine | 18 | $378 | $21 |
| Methadone | 21 | $328 | $16 |
| Zolpidem | 24 | $321 | $13 |
| Cyclobenzaprine | 13 | $189 | $15 |
| Mirtazapine | 12 | $120 | $10 |
| Methylprednisolone | 12 | $114 | $10 |
| Diazepam | 41 | $47 | $1 |
| Meloxicam | 15 | $42 | $3 |
2020: 26 drugs
| Oxycontin | 67 | $35,521 | $530 |
| Lidocaine | 63 | $10,882 | $173 |
| Hydrocodone-Acetaminophen | 336 | $9,715 | $29 |
| Oxycodone-Acetaminophen | 190 | $7,121 | $37 |
| Oxycodone | 202 | $6,958 | $34 |
| Pregabalin | 79 | $5,104 | $65 |
| Celecoxib | 78 | $4,041 | $52 |
| Morphine Sulfate Er | 161 | $3,893 | $24 |
| Gabapentin | 220 | $3,666 | $17 |
| Tizanidine | 102 | $3,613 | $35 |
| Fentanyl | 36 | $3,483 | $97 |
| Diclofenac | 71 | $2,896 | $41 |
| Hydromorphone | 98 | $2,364 | $24 |
| Narcan | 12 | $1,533 | $128 |
| Duloxetine | 48 | $1,113 | $23 |
| Amitriptyline | 38 | $984 | $26 |
| Methocarbamol | 86 | $961 | $11 |
| Morphine Sulfate | 24 | $733 | $31 |
| Cyclobenzaprine | 42 | $629 | $15 |
| Methadone | 37 | $622 | $17 |
| Baclofen | 13 | $595 | $46 |
| Zolpidem | 37 | $225 | $6 |
| Mirtazapine | 15 | $217 | $14 |
| Meloxicam | 27 | $200 | $7 |
| Tramadol | 22 | $197 | $9 |
| Clonidine | 18 | $108 | $6 |
2019: 37 drugs
| Lyrica | 76 | $54,364 | $715 |
| Oxycontin | 72 | $41,054 | $570 |
| Hydrocodone-Acetaminophen | 532 | $16,091 | $30 |
| Lidocaine | 93 | $13,070 | $141 |
| Oxycodone | 355 | $12,609 | $36 |
| Morphine Sulfate Er | 295 | $9,076 | $31 |
| Oxycodone-Acetaminophen | 242 | $7,839 | $32 |
| Narcan | 59 | $7,748 | $131 |
| Diclofenac | 122 | $7,299 | $60 |
| Celecoxib | 128 | $7,221 | $56 |
| Gabapentin | 348 | $7,103 | $20 |
| Hydromorphone | 118 | $4,096 | $35 |
| Fentanyl | 42 | $3,434 | $82 |
| Pregabalin | 46 | $3,302 | $72 |
| Duloxetine | 99 | $3,298 | $33 |
| Tizanidine | 158 | $2,838 | $18 |
| Voltaren | 21 | $2,131 | $101 |
| Morphine Sulfate | 45 | $1,593 | $35 |
| Amitriptyline | 73 | $1,326 | $18 |
| Methadone | 88 | $1,285 | $15 |
| Cyclobenzaprine | 86 | $1,208 | $14 |
| Venlafaxine Hcl Er | 37 | $966 | $26 |
| Methocarbamol | 64 | $805 | $13 |
| Mirtazapine | 67 | $804 | $12 |
| Baclofen | 34 | $525 | $15 |
| Meloxicam | 57 | $499 | $9 |
| Ibuprofen | 38 | $433 | $11 |
| Topiramate | 31 | $335 | $11 |
| Sumatriptan | 15 | $305 | $20 |
| Tramadol | 35 | $273 | $8 |
| Omeprazole | 13 | $265 | $20 |
| Zolpidem | 42 | $246 | $6 |
| Clonidine | 31 | $195 | $6 |
| Ondansetron Odt | 12 | $183 | $15 |
| Trazodone | 19 | $163 | $9 |
| Cephalexin | 12 | $94 | $8 |
| Nortriptyline | 13 | $76 | $6 |
2018: 35 drugs
| Lyrica | 106 | $63,968 | $603 |
| Oxycontin | 59 | $38,844 | $658 |
| Hydrocodone-Acetaminophen | 539 | $18,526 | $34 |
| Morphine Sulfate Er | 348 | $13,389 | $38 |
| Oxycodone | 364 | $13,025 | $36 |
| Lidocaine | 59 | $9,626 | $163 |
| Celecoxib | 107 | $7,790 | $73 |
| Gabapentin | 315 | $7,683 | $24 |
| Oxycodone-Acetaminophen | 194 | $7,076 | $36 |
| Fentanyl | 65 | $4,839 | $74 |
| Duloxetine | 131 | $4,284 | $33 |
| Diclofenac | 83 | $3,932 | $47 |
| Hydromorphone | 165 | $3,585 | $22 |
| Voltaren | 38 | $3,558 | $94 |
| Tizanidine | 164 | $2,595 | $16 |
| Methadone | 102 | $1,683 | $16 |
| Cyclobenzaprine | 87 | $1,465 | $17 |
| Amitriptyline | 84 | $1,391 | $17 |
| Venlafaxine Hcl Er | 26 | $1,072 | $41 |
| Sumatriptan | 29 | $986 | $34 |
| Morphine Sulfate | 34 | $983 | $29 |
| Mirtazapine | 69 | $748 | $11 |
| Baclofen | 61 | $727 | $12 |
| Topiramate | 45 | $529 | $12 |
| Zolpidem | 58 | $459 | $8 |
| Meloxicam | 74 | $413 | $6 |
| Tramadol | 36 | $380 | $11 |
| Methocarbamol | 49 | $369 | $8 |
| Methylphenidate | 12 | $357 | $30 |
| Ibuprofen | 41 | $327 | $8 |
| Ondansetron | 15 | $235 | $16 |
| Trazodone | 28 | $194 | $7 |
| Citalopram Hbr | 11 | $150 | $14 |
| Clonidine | 16 | $87 | $5 |
| Cephalexin | 14 | $80 | $6 |
2017: 43 drugs
| Lyrica | 96 | $56,132 | $585 |
| Oxycontin | 60 | $48,579 | $810 |
| Morphine Sulfate Er | 315 | $18,236 | $58 |
| Oxycodone | 348 | $15,331 | $44 |
| Fentanyl | 137 | $14,734 | $108 |
| Lidocaine | 70 | $13,120 | $187 |
| Hydrocodone-Acetaminophen | 509 | $11,464 | $23 |
| Oxycodone-Acetaminophen | 219 | $8,394 | $38 |
| Gabapentin | 277 | $7,322 | $26 |
| Gralise | 13 | $6,564 | $505 |
| Oxymorphone Hcl Er | 17 | $5,280 | $311 |
| Duloxetine | 102 | $4,790 | $47 |
| Diclofenac | 80 | $4,317 | $54 |
| Voltaren | 52 | $4,050 | $78 |
| Hydromorphone | 153 | $3,456 | $23 |
| Celecoxib | 47 | $3,214 | $68 |
| Methadone | 125 | $2,577 | $21 |
| Cyclobenzaprine | 104 | $1,667 | $16 |
| Tizanidine | 128 | $1,496 | $12 |
| Tramadol Hcl Er | 18 | $1,408 | $78 |
| Venlafaxine Hcl Er | 26 | $1,392 | $54 |
| Baclofen | 60 | $1,083 | $18 |
| Amitriptyline | 72 | $1,061 | $15 |
| Morphine Sulfate | 35 | $896 | $26 |
| Codeine Sulfate | 11 | $660 | $60 |
| Acetaminophen-Codeine | 15 | $646 | $43 |
| Topiramate | 40 | $622 | $16 |
| Zolpidem | 134 | $581 | $4 |
| Sumatriptan | 22 | $575 | $26 |
| Methocarbamol | 56 | $548 | $10 |
| Escitalopram | 18 | $524 | $29 |
| Methylphenidate | 13 | $467 | $36 |
| Zolpidem Tartrate Er | 11 | $263 | $24 |
| Meloxicam | 57 | $251 | $4 |
| Bupropion Xl | 11 | $250 | $23 |
| Tramadol | 23 | $242 | $11 |
| Clonidine | 26 | $200 | $8 |
| Lidocaine | 14 | $143 | $10 |
| Naproxen | 17 | $130 | $8 |
| Ibu | 11 | $115 | $10 |
| Trazodone | 20 | $103 | $5 |
| Ibuprofen | 20 | $99 | $5 |
| Cephalexin | 13 | $61 | $5 |
2016: 40 drugs
| Lyrica | 80 | $37,692 | $471 |
| Oxycontin | 42 | $36,899 | $879 |
| Lidocaine | 56 | $17,740 | $317 |
| Fentanyl | 130 | $17,472 | $134 |
| Morphine Sulfate Er | 202 | $16,528 | $82 |
| Hydrocodone-Acetaminophen | 400 | $15,859 | $40 |
| Oxycodone | 254 | $12,242 | $48 |
| Oxycodone-Acetaminophen | 153 | $8,725 | $57 |
| Norco | 13 | $7,430 | $572 |
| Gralise | 15 | $7,340 | $489 |
| Opana Er | 14 | $6,079 | $434 |
| Oxymorphone Hcl Er | 14 | $4,343 | $310 |
| Hydromorphone | 127 | $3,791 | $30 |
| Gabapentin | 158 | $3,738 | $24 |
| Celecoxib | 31 | $3,016 | $97 |
| Tramadol Hcl Er | 17 | $2,669 | $157 |
| Methadone | 115 | $2,570 | $22 |
| Voltaren | 34 | $2,215 | $65 |
| Duloxetine | 61 | $2,061 | $34 |
| Diclofenac | 22 | $1,490 | $68 |
| Acetaminophen-Codeine | 22 | $1,186 | $54 |
| Tizanidine | 58 | $1,021 | $18 |
| Amitriptyline | 60 | $985 | $16 |
| Baclofen | 45 | $761 | $17 |
| Escitalopram | 11 | $701 | $64 |
| Lorazepam | 15 | $651 | $43 |
| Zolpidem | 92 | $590 | $6 |
| Morphine Sulfate | 30 | $590 | $20 |
| Cyclobenzaprine | 44 | $399 | $9 |
| Topiramate | 17 | $327 | $19 |
| Venlafaxine Hcl Er | 14 | $282 | $20 |
| Tramadol | 16 | $247 | $15 |
| Sumatriptan | 16 | $226 | $14 |
| Methocarbamol | 13 | $206 | $16 |
| Naproxen | 23 | $183 | $8 |
| Ibuprofen | 15 | $151 | $10 |
| Lidocaine | 11 | $122 | $11 |
| Meloxicam | 36 | $118 | $3 |
| Trazodone | 11 | $64 | $6 |
| Diazepam | 13 | $51 | $4 |
2015: 20 drugs
| Morphine Sulfate Er | 232 | $37,653 | $162 |
| Oxycontin | 48 | $37,494 | $781 |
| Lyrica | 59 | $23,181 | $393 |
| Hydrocodone-Acetaminophen | 424 | $18,176 | $43 |
| Fentanyl | 88 | $14,058 | $160 |
| Oxycodone | 258 | $13,046 | $51 |
| Oxycodone-Acetaminophen | 155 | $11,334 | $73 |
| Lidoderm | 12 | $9,622 | $802 |
| Norco | 13 | $6,228 | $479 |
| Hydromorphone | 133 | $4,908 | $37 |
| Oxymorphone Hcl Er | 13 | $4,574 | $352 |
| Opana Er | 15 | $3,884 | $259 |
| Methadone | 130 | $3,374 | $26 |
| Zolpidem | 92 | $1,412 | $15 |
| Acetaminophen-Codeine | 20 | $1,030 | $51 |
| Codeine Sulfate | 11 | $626 | $57 |
| Morphine Sulfate | 35 | $547 | $16 |
| Lorazepam | 12 | $530 | $44 |
| Diazepam | 51 | $192 | $4 |
| Tramadol | 12 | $111 | $9 |
2014: 23 drugs
| Morphine Sulfate Er | 235 | $46,184 | $197 |
| Oxycodone | 172 | $16,056 | $93 |
| Hydrocodone-Acetaminophen | 350 | $12,247 | $35 |
| Oxycodone-Acetaminophen | 147 | $10,660 | $73 |
| Fentanyl | 72 | $9,696 | $135 |
| Lyrica | 35 | $9,152 | $261 |
| Lidoderm | 11 | $8,792 | $799 |
| Norco | 13 | $5,054 | $389 |
| Oxycontin | 17 | $4,881 | $287 |
| Hydromorphone | 120 | $3,586 | $30 |
| Gabapentin | 11 | $2,455 | $223 |
| Opana Er | 13 | $2,329 | $179 |
| Methadone | 85 | $1,632 | $19 |
| Valium | 12 | $1,094 | $91 |
| Morphine Sulfate | 27 | $626 | $23 |
| Endocet | 19 | $612 | $32 |
| Codeine Sulfate | 12 | $576 | $48 |
| Acetaminophen-Codeine | 25 | $551 | $22 |
| Zolpidem | 88 | $514 | $6 |
| Butalb-Caff-Acetaminoph-Codein | 13 | $442 | $34 |
| Diazepam | 62 | $277 | $4 |
| Temazepam | 14 | $67 | $5 |
| Clonazepam | 12 | $58 | $5 |
2013: 17 drugs
| Morphine Sulfate Er | 218 | $25,661 | $118 |
| Hydrocodone-Acetaminophen | 335 | $9,611 | $29 |
| Lyrica | 37 | $9,574 | $259 |
| Oxycodone | 139 | $7,782 | $56 |
| Fentanyl | 49 | $7,245 | $148 |
| Oxycodone Hcl-Acetaminophen | 79 | $4,445 | $56 |
| Hydromorphone | 50 | $1,973 | $39 |
| Gabapentin | 21 | $1,264 | $60 |
| Methadone | 52 | $852 | $16 |
| Morphine Sulfate | 26 | $812 | $31 |
| Acetaminophen-Codeine | 24 | $623 | $26 |
| Butalb-Caff-Acetaminoph-Codein | 11 | $488 | $44 |
| Oxycodone-Acetaminophen | 24 | $424 | $18 |
| Zolpidem | 74 | $407 | $5 |
| Diazepam | 37 | $203 | $5 |
| Alendronate | 12 | $100 | $8 |
| Temazepam | 14 | $69 | $5 |
Money from drug and device companies
$1,036 in 2025
| 2025 | 9 | 30 | None | $1,036 |
| 2024 | 5 | 14 | None | $270 |
| 2023 | 2 | 26 | None | $591 |
| 2022 | 3 | 9 | None | $229 |
| 2021 | 3 | 4 | None | $85 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbott Laboratories | Proclaim | $440 | 11 payments
|
| Abbvie | Qulipta | $215 | 10 payments
|
| Vertex Pharmaceuticals | Journavx | $103 | 1 payment
|
| Boston Scientific | Intracept | $98 | 2 payments
|
| SPR Therapeutics | Sprint Pns System | $53 | 2 payments
|
| Mml US | Reactiv8 | $48 | 1 payment
|
See all 30 published payments
| Abbott Laboratories | Meals · 2025-12-26 | Proclaim | $23 |
| Abbvie | Meals · 2025-12-23 | Qulipta | $28 |
| Abbott Laboratories | Meals · 2025-12-05 | Eterna | $3 |
| Abbvie | Meals · 2025-11-24 | Qulipta | $28 |
| Vertex Pharmaceuticals | Meals · 2025-11-18 | Journavx | $103 |
| Abbott Laboratories | Meals · 2025-11-12 | Proclaim | $135 |
| SPR Therapeutics | Meals · 2025-10-23 | Sprint Pns System | $25 |
| Abbott Laboratories | Meals · 2025-10-15 | Eterna | $25 |
| Abbvie | Meals · 2025-10-03 | Botox | $24 |
| Abbott Laboratories | Meals · 2025-09-08 | Proclaim | $11 |
| Abbott Laboratories | Meals · 2025-09-04 | Proclaim | $174 |
| Abbott Laboratories | Meals · 2025-09-03 | Eterna | $7 |
| Boston Scientific | Meals · 2025-08-28 | Intracept | $70 |
| Abbvie | Meals · 2025-08-22 | Qulipta | $28 |
| Abbott Laboratories | Meals · 2025-07-17 | Proclaim | $9 |
| Spinal Simplicity | Meals · 2025-06-05 | Ha Minuteman G3-R | $25 |
| Mml US | Meals · 2025-06-01 | Reactiv8 | $48 |
| Abbvie | Meals · 2025-05-30 | Qulipta | $26 |
| Boston Scientific | Meals · 2025-05-23 | Intracept | $28 |
| Abbvie | Meals · 2025-05-23 | Botox | $20 |
| Abbvie | Meals · 2025-05-15 | Botox | $19 |
| SPR Therapeutics | Meals · 2025-05-08 | Sprint Pns System | $28 |
| Abbvie | Meals · 2025-05-02 | Botox | $2 |
| Medtronic | Meals · 2025-05-01 | Inceptiv | $30 |
| Abbvie | Meals · 2025-03-26 | Qulipta | $9 |
| Abbott Laboratories | Meals · 2025-03-19 | Eterna | $15 |
| Fidia Pharma USA | Meals · 2025-02-07 | Hymovis | $26 |
| Abbvie | Meals · 2025-01-30 | Qulipta | $29 |
| Abbott Laboratories | Meals · 2025-01-22 | Proclaim | $14 |
| Abbott Laboratories | Meals · 2025-01-09 | Proclaim | $23 |
See earlier years (2024, 2023, 2022, 2021)
2024: $270
| Abbvie | Qulipta | $142 | 8 payments
|
| Abbott Laboratories | Proclaim | $62 | 3 payments
|
| Boston Scientific | None | $26 | 1 payment
|
| Merz Pharmaceuticals | Xeomin | $24 | 1 payment
|
| Curonix | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A | $17 | 1 payment
|
2023: $591
| Abbott Laboratories | Proclaim | $425 | 14 payments
|
| Abbvie | Qulipta | $166 | 12 payments
|
2022: $229
| Abbott Laboratories | Proclaim | $191 | 7 payments
|
| Merz Pharmaceuticals | Xeomin | $21 | 1 payment
|
| Medtronic | Intellis Adaptivestim | $18 | 1 payment
|
2021: $85
| AbbVie | Qulipta | $52 | 2 payments
|
| Nalu Medical | Nalu Neurostimulation System | $19 | 1 payment
|
| Allergan | Botox | $14 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 99.2 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1114087145
- Licence
- CA PA15150
- Trained
- Un of California, Irvine, College of Medicine, 1999 · 27 years ago
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Physician assistant, medical (363AM0700X)
- Mailing address
- 18 Peninsula Ct, Napa, CA, 94559
- NPI first listed
- 2006-12-11
- NPI last updated
- 2009-08-10
This is when the NPI record was last certified, not a medical board exam.